It was 2023 when Ontario Genomics waded into the enticing waters of commercialization to launch the BioCreate accelerator program and funded our first round of eight SMEs. With backing from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), OG has seen remarkable results so far with this $11.6-million, 5-year project giving up to 32-companies funding and business support.
We’re currently nurturing 24 high potential start-ups in the health, food and agriculture, and cleantech sectors to help them efficiently get their products and technologies to market and our prestigious accelerator is already getting national and international recognition. One of the reasons why is because getting into BioCreate isn’t easy! Our panel of experts from the business, science, company creation and tech worlds help vet all potential companies for the viability of their product or process and how it can be put to use in the real world, which is why we only have a 15% acceptance rate.
That stringent process has yielded phenomenal outcomes with BioCreate companies:
Jobs
Follow-On Investments
Sales & Revenue
Intellectual Property
These are highly encouraging numbers and we’re only halfway through the program! BioCreate companies are thriving and CEOs have told us we’re different from other accelerators because of our responsiveness to their needs and industry demands. We’re connecting them with mentors and investors, finding networking opportunities for them at OG events, and our agile and unique mentorship offerings include media training and company promo videos. To see them for yourself, head over to BioCreate.ca.